| Year |
Citation |
Score |
| 1995 |
Tuinier S, Verhoeven WM, van Praag HM. Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. International Clinical Psychopharmacology. 10: 147-56. PMID 8675967 |
0.505 |
|
| 1992 |
Kahn RS, van Praag HM. Panic disorder: a biological perspective. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2: 1-20. PMID 1638169 DOI: 10.1016/0924-977X(92)90031-3 |
0.333 |
|
| 1992 |
Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects. Psychopharmacology. 106: 388-90. PMID 1533289 DOI: 10.1007/BF02245423 |
0.302 |
|
| 1992 |
Asnis GM, Wetzler S, Sanderson WC, Kahn RS, van Praag HM. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Research. 43: 65-76. PMID 1438618 DOI: 10.1016/0165-1781(92)90142-P |
0.401 |
|
| 1991 |
Wetzler S, Kahn RS, Asnis GM, Korn M, van Praag HM. Serotonin receptor sensitivity and aggression. Psychiatry Research. 37: 271-9. PMID 1891509 DOI: 10.1016/0165-1781(91)90063-U |
0.361 |
|
| 1991 |
Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biological Psychiatry. 30: 770-8. PMID 1751620 DOI: 10.1016/0006-3223(91)90233-C |
0.349 |
|
| 1991 |
Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research. 37: 25-34. PMID 1650487 DOI: 10.1016/0165-1781(91)90103-V |
0.301 |
|
| 1990 |
Kahn RS, van Praag HM. Panic disorder: a presynaptic serotonin defect? Psychiatry Research. 31: 209-10. PMID 2326399 DOI: 10.1016/0165-1781(90)90123-M |
0.304 |
|
| 1990 |
Wetzler S, Kahn RS, Cahn W, van Praag HM, Asnis GM. Psychological test characteristics of depressed and panic patients. Psychiatry Research. 31: 179-92. PMID 2326397 DOI: 10.1016/0165-1781(90)90120-T |
0.351 |
|
| 1990 |
Van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology. Annals of the New York Academy of Sciences. 600: 501-10. PMID 2252329 |
0.356 |
|
| 1990 |
Kahn RS, Kalus O, Wetzler S, Cahn W, Asnis GM, van Praag HM. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Psychiatry Research. 33: 189-98. PMID 2243896 DOI: 10.1016/0165-1781(90)90073-E |
0.354 |
|
| 1990 |
Kahn RS, Wetzler S, Asnis GM, Papolos D, van Praag HM. Serotonin receptor sensitivity in major depression. Biological Psychiatry. 28: 358-62. PMID 2204434 DOI: 10.1016/0006-3223(90)90663-M |
0.382 |
|
| 1990 |
Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology. 100: 339-44. PMID 2156278 DOI: 10.1007/BF02244603 |
0.309 |
|
| 1990 |
van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Monoamines and abnormal behaviour. A multi-aminergic perspective. The British Journal of Psychiatry : the Journal of Mental Science. 157: 723-34. PMID 1980627 |
0.35 |
|
| 1988 |
Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G. Serotonin and anxiety revisited. Biological Psychiatry. 23: 189-208. PMID 3275471 DOI: 10.1016/0006-3223(88)90091-1 |
0.37 |
|
| 1988 |
Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Research. 25: 101-4. PMID 3217461 DOI: 10.1016/0165-1781(88)90163-1 |
0.389 |
|
| 1988 |
van Praag HM, Kahn RS. L-5-hydroxytryptophan in depression and anxiety. Schweizerische Rundschau Fã¼R Medizin Praxis = Revue Suisse De Mã©Decine Praxis. 77: 40-6. PMID 3055148 |
0.358 |
|
| 1988 |
Kahn RS, Asnis GM, Wetzler S, van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology. 96: 360-4. PMID 2906153 DOI: 10.1007/BF00216062 |
0.367 |
|
| 1987 |
van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. Journal of Affective Disorders. 13: 1-8. PMID 2959695 DOI: 10.1016/0165-0327(87)90067-X |
0.336 |
|
| 1984 |
Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4 |
0.615 |
|
| 1981 |
Verhoeven WM, van Praag HM, de Jong JT. Use of naloxone in schizophrenic psychoses and manic syndromes. Neuropsychobiology. 7: 159-68. PMID 7231653 DOI: 10.1159/000117845 |
0.478 |
|
| 1981 |
van Praag HM, Verhoeven WM. Neuropeptides. A new dimension in biological psychiatry. Progress in Brain Research. 53: 229-52. PMID 7005944 DOI: 10.1016/S0079-6123(08)60067-9 |
0.454 |
|
| 1981 |
Van Praag HM, Verhoeven WM. Endorphin research in schizophrenic psychoses. Comprehensive Psychiatry. 22: 135-46. PMID 6260424 DOI: 10.1016/0010-440X(81)90061-4 |
0.44 |
|
| 1977 |
Westenberg HG, Drenth BF, de Zeeuw RA, de Cuyper H, van Praag HM, Korf J. Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography. Journal of Chromatography. 142: 725-33. PMID 914945 |
0.426 |
|
| 1977 |
Westerink BH, Lejeune B, Korf J, Van Praag HM. On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs. European Journal of Pharmacology. 42: 179-90. PMID 844497 |
0.499 |
|
| 1977 |
Westenberg HG, De Zeeuw RA, De Cuyper H, Van Praag HM, Korf J. Bioanalysis and pharmacokinetics of clomipramine and desmethylclomipramine in man by means of liquid chromatography. Postgraduate Medical Journal. 53: 124-30. PMID 600889 |
0.417 |
|
| 1977 |
Van der Poel FW, Van Praag HM, Korf J. Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space. Psychopharmacology. 52: 35-40. PMID 403555 |
0.459 |
|
| 1977 |
Van Scheyen JD, Van Praag HM, Korf J. Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique. British Journal of Clinical Pharmacology. 4: 179S-184S. PMID 334221 |
0.536 |
|
| 1976 |
van Praag HM, Korf J, Lequin RM. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin. Psychopharmacology Communications. 2: 369-78. PMID 1088302 |
0.488 |
|
| 1976 |
Van Praag HM, Korf J, Dols LC. Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity. The British Journal of Psychiatry : the Journal of Mental Science. 129: 547-55. PMID 1000139 |
0.479 |
|
| 1976 |
Van Praag HM, Korf J. Importance of dopamine metabolism for clinical effects and side effects of neuroleptics. The American Journal of Psychiatry. 133: 1171-7. PMID 970488 |
0.499 |
|
| 1976 |
Korf J, Sebens JB, Venema K, van Praag HM. Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester. Research Communications in Chemical Pathology and Pharmacology. 15: 171-82. PMID 968174 |
0.489 |
|
| 1976 |
van Praag HM, Korf J. 4-chloroamphetamines. Chance and trend in the development of new antidepressants. Psychopharmacology Bulletin. 12: 64-74. PMID 785522 |
0.467 |
|
| 1975 |
van Praag HM, Korf J. Central monoamine deficiency in depressions: causative of secondary phenomenon? Pharmakopsychiatrie, Neuro-Psychopharmakologie. 8: 322-6. PMID 1085937 DOI: 10.1055/s-0028-1094463 |
0.532 |
|
| 1975 |
van Praag HM, Korf J. Biochemical research into psychosis. Acta Psychiatrica Scandinavica. 51: 268-84. PMID 238363 |
0.516 |
|
| 1975 |
Van Praag HM, Korf J. Neuroleptics, catecholamines, and psychoses: a study of their interrelations. The American Journal of Psychiatry. 132: 593-7. PMID 235848 |
0.493 |
|
| 1974 |
van Praag HM, Korf J. Serotonin metabolism in depression: clinical application of the probenecid test. International Pharmacopsychiatry. 9: 35-51. PMID 4599325 |
0.545 |
|
| 1974 |
van Praag HM, Korf J. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test. The Journal of Nervous and Mental Disease. 158: 331-7. PMID 4596091 |
0.467 |
|
| 1974 |
Korf J, van Praag HM, Schut D, Nienhuis RJ, Lakke JP. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy. European Neurology. 12: 340-50. PMID 4448192 DOI: 10.1159/000114631 |
0.45 |
|
| 1973 |
van Praag HM, Flentge F, Korf J, Dols LC, Schut T. The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man. Psychopharmacologia. 33: 141-51. PMID 4775879 |
0.506 |
|
| 1973 |
van Praag HM, Korf J, Schut D. Cerebral monoamines and depression. An investigation with the Probenecid technique. Archives of General Psychiatry. 28: 827-31. PMID 4707990 |
0.497 |
|
| 1973 |
Lakke JP, Korf J, Hoorntje S, Schut T, van Praag HM. The probenecid test in Parkinson's disease. Psychiatria, Neurologia, Neurochirurgia. 76: 139-46. PMID 4700931 |
0.435 |
|
| 1973 |
van Praag HM, Korf J. 4-Chloramphetamines. Chance and trend in the development of new antidepressants. The Journal of Clinical Pharmacology and New Drugs. 13: 3-14. PMID 4566121 |
0.465 |
|
| 1973 |
Lakke JP, Korf J, van Praag HM, Minderhoud JM, Schut T. Clinical significance of probenecid test. Lancet. 1: 614-5. PMID 4120687 DOI: 10.1016/S0140-6736(73)90770-8 |
0.437 |
|
| 1972 |
Korf J, Van Praag HM, Sebens JB. Serum tryptophan decreased, brain tryptophan increased and brain serotonin synthesis unchanged after probenecid loading. Brain Research. 42: 239-42. PMID 5047195 |
0.443 |
|
| 1972 |
van Praag HM, Korf J, Dols LC, Schut T. A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia. 25: 14-21. PMID 4556909 |
0.47 |
|
| 1972 |
Lakke JP, Korf J, Van Praag HM, Schut T. [Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease]. Nature: New Biology. 236: 208-9. PMID 4553111 |
0.456 |
|
| 1972 |
Korf J, van Praag HM. Action of p-chloroamphetamine on cerebral serotonin metabolism: an hypothesis. Neuropharmacology. 11: 141-4. PMID 4110561 |
0.487 |
|
| 1971 |
Korf J, van Praag HM. Retarded depression and the dopamine metabolism. Psychopharmacologia. 19: 199-203. PMID 5565740 |
0.539 |
|
| 1971 |
Korf J, van Praag HM. Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification? Psychopharmacologia. 19: 148-52. PMID 5565735 |
0.533 |
|
| 1971 |
van Praag HM, Korf J. [Are disturbances in the central metabolism of dopamine specific for Parkinson's syndrome?]. Nederlands Tijdschrift Voor Geneeskunde. 115: 514-5. PMID 5546941 |
0.481 |
|
| 1971 |
Korf J, van Praag HM, Sebens JB. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochemical Pharmacology. 20: 659-68. PMID 5150161 |
0.451 |
|
| 1971 |
van Praag HM, Korf J. [Current developments in the field of antidepressive agents]. Nederlands Tijdschrift Voor Geneeskunde. 115: 1963-70. PMID 5148103 |
0.437 |
|
| 1971 |
Korf J, Van Praag HM. Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Research. 35: 221-30. PMID 5134227 |
0.47 |
|
| 1971 |
van Praag HM, Korf J. A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biological Psychiatry. 3: 105-12. PMID 5089909 |
0.532 |
|
| 1971 |
Lakke JP, Korf J, van Praag HM. Predicting response to levodopa. Lancet. 2: 164-5. PMID 4104491 |
0.425 |
|
| 1970 |
van Praag HM, Korf J, Puite J. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature. 225: 1259-60. PMID 5435360 |
0.515 |
|
| 1970 |
van Woudenberg F, Wiegman T, van Praag HM, Korf J. Investigation of the influence of p-chloro-N-methamphetamine on the human metabolism of 5-hydroxytryptamine with high voltage electrophoresis and liquid scintillation counting. Clinica Chimica Acta; International Journal of Clinical Chemistry. 27: 313-5. PMID 5417229 |
0.458 |
|
| 1970 |
Korf J, van Praag HM. The intravenous probenecid test: a possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depressions. Psychopharmacologia. 18: 129-32. PMID 4943187 |
0.535 |
|
| 1970 |
van Praag HM, Korf J, van Woudenberg F. Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man. Psychopharmacologia. 18: 412-20. PMID 4923523 |
0.453 |
|
| 1970 |
van Praag HM, Korf J. L-tryptophan in depression. Lancet. 2: 612. PMID 4195577 |
0.497 |
|
| 1969 |
van Praag HM, Korf J, van Woudenberg F, Kits TP. An attempt at indirect evaluation of the noradrenaline hypothesis. Psychiatria, Neurologia, Neurochirurgia. 72: 181-7. PMID 5792058 |
0.443 |
|
| 1968 |
van Praag HM, Korf J, van Woudenberg F, Kits TP. Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-chloro-N-methylamphetamine). Psychopharmacologia. 13: 145-60. PMID 5678577 |
0.49 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1986 |
Van Praag HM. Affective disorders and aggression disorders: evidence for a common biological mechanism Suicide and Life-Threatening Behavior. 16: 103-132. PMID 2428139 |
0.275 |
|
| 1989 |
Kahn RS, Cahn W, van Praag HM. [Pathogenesis of panic disorders]. Nederlands Tijdschrift Voor Geneeskunde. 133: 498-501. PMID 2651934 |
0.269 |
|
| 1996 |
van Praag HM. Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression) Psychiatry Research. 65: 143-57. PMID 9029663 DOI: 10.1016/S0165-1781(96)02923-X |
0.257 |
|
| 1998 |
van Praag HM. Anxiety and increased aggression as pacemakers of depression. Acta Psychiatrica Scandinavica. Supplementum. 393: 81-8. PMID 9777052 |
0.251 |
|
| 2002 |
Riedel WJ, Klaassen T, Griez E, Honig A, Menheere PP, van Praag HM. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 358-67. PMID 11850150 DOI: 10.1016/S0893-133X(01)00361-X |
0.248 |
|
| 1980 |
van Praag HM. Central monoamine metabolism in depressions. I. Serotonin and related compounds. Comprehensive Psychiatry. 21: 30-43. PMID 6153593 DOI: 10.1016/0010-440x(80)90062-0 |
0.245 |
|
| 1987 |
Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, Van Praag HM, Rubinson E, Eisenberg J. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity Journal of Affective Disorders. 12: 219-221. PMID 2956306 DOI: 10.1016/0165-0327(87)90030-9 |
0.243 |
|
| 1994 |
Van Praag HM. 5-HT-related, anxiety- and/or aggression-driven depression. International Clinical Psychopharmacology. 9: 5-6. PMID 7517413 |
0.241 |
|
| 1990 |
Kalus O, Kahn RS, Wetzler S, Asnis GM, van Praag HM. Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks. Biological Psychiatry. 28: 1053-7. PMID 2288999 DOI: 10.1016/0006-3223(90)90606-3 |
0.238 |
|
| 1976 |
van Praag HM. Therapy-resistant depressions: biochemical and pharmacological considerations. International Journal of Psychiatry in Medicine. 6: 99-111. PMID 773865 DOI: 10.2190/3UN1-XLMK-RLGE-C4JF |
0.237 |
|
| 1996 |
Van Praag HM. Stressor-susceptibility, cortisol-hypersecretion, and serotonin deficiency. The major determinants of a hypothetical subtype of depression European Neuropsychopharmacology. 6: 5-6. |
0.236 |
|
| 1986 |
Van Praag HM, Plutchik R, Conte H. The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence. Annals of the New York Academy of Sciences. 487: 150-67. PMID 2436530 DOI: 10.1111/J.1749-6632.1986.Tb27895.X |
0.236 |
|
| 1989 |
van Praag HM. Moving ahead yet falling behind. A critical appraisal of some trends in contemporary depression research. Neuropsychobiology. 22: 181-93. PMID 2577242 DOI: 10.1159/000118616 |
0.231 |
|
| 1996 |
Van Praag HM. Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression. A psycho-biological hypothesis European Psychiatry. 11: 57-67. DOI: 10.1016/0924-9338(96)84782-1 |
0.229 |
|
| 1997 |
van Praag HM. [Treatment of refractory primary depression]. Nederlands Tijdschrift Voor Geneeskunde. 141: 1375-9. PMID 9380197 |
0.226 |
|
| 2001 |
Van Praag HM. Anxiety/aggression--driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 893-924. PMID 11383984 DOI: 10.1016/S0278-5846(01)00151-8 |
0.226 |
|
| 1998 |
van Praag HM. Inflationary tendencies in judging the yield of depression research. Neuropsychobiology. 37: 130-41. PMID 9597669 DOI: 10.1159/000026492 |
0.224 |
|
| 1994 |
van Praag HM. Anxiety and aggression as pacemakers of serotonin-related depression European Neuropsychopharmacology. 4: 196-197. DOI: 10.1016/0924-977X(94)90033-7 |
0.221 |
|
| 1990 |
Apter A, van Praag HM, Plutchik R, Sevy S, Korn M, Brown SL. Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Research. 32: 191-9. PMID 2367604 DOI: 10.1016/0165-1781(90)90086-K |
0.221 |
|
| 1989 |
van Praag HM. Diagnosing depression--looking backward into the future. Psychiatric Developments. 7: 375-94. PMID 2487902 |
0.221 |
|
| 1999 |
van Praag HM. On what evidence should education concerning depression be based? International Clinical Psychopharmacology. 14: S35-9. PMID 10468332 DOI: 10.1097/00004850-199906003-00006 |
0.218 |
|
| 1987 |
van Praag HM, Kahn R, Asnis GM, Lemus CZ, Brown SL. Therapeutic indications for serotonin-potentiating compounds: A hypothesis Biological Psychiatry. 22: 205-212. PMID 2434148 DOI: 10.1016/0006-3223(87)90232-0 |
0.218 |
|
| 1998 |
van PRAAG H, LEIJNSE B. The influence of some antidepressives of the hydrazine type on the glucose metabolism in depressed patients. Clinica Chimica Acta; International Journal of Clinical Chemistry. 8: 466-75. PMID 13985880 DOI: 10.1016/0009-8981(63)90088-3 |
0.217 |
|
| 2002 |
Van Praag HM. Anxiety/aggression-driven depression. A hypothesis concerning a new type of depression | Angst/agressiegeïnduceerde depressie. Een hypothese betreffende een nieuw depressietype Tijdschrift Voor Psychiatrie. 44: 183-192. |
0.215 |
|
| 1995 |
van Praag HM. Concerns about depression. European Psychiatry : the Journal of the Association of European Psychiatrists. 10: 269-75. PMID 19698353 DOI: 10.1016/0924-9338(96)80307-5 |
0.214 |
|
| 2002 |
Klaassen T, Riedel WJ, van Praag HM, Menheere PP, Griez E. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Research. 113: 29-40. PMID 12467943 |
0.213 |
|
| 2000 |
Van Praag HM. Does biological depression research enrich the diagnosis of depression? | Verrijkt biologisch depressieonderzoek de diagnostiek van depressies? Tijdschrift Voor Psychiatrie. 42: 11-18. |
0.207 |
|
| 1998 |
van Praag HM. The diagnosis of depression in disorder. The Australian and New Zealand Journal of Psychiatry. 32: 767-72; discussion 7. PMID 10084340 |
0.206 |
|
| 2004 |
van Praag HM. Can stress cause depression? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 891-907. PMID 15363612 DOI: 10.1016/j.pnpbp.2004.05.031 |
0.206 |
|
| 2005 |
van Praag HM. Can stress cause depression? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 6: 5-22. PMID 16166019 DOI: 10.1080/15622970510030018 |
0.206 |
|
| 1999 |
Van Praag HM. Towards a biochemical typology of depression? | Naar een biochemische typologie van depressies? Tijdschrift Voor Psychiatrie. 41: 27-45. |
0.206 |
|
| 1992 |
Asnis GM, Sanderson WC, van Praag HM. Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: a replication study. Psychiatry Research. 44: 237-50. PMID 1289921 DOI: 10.1016/0165-1781(92)90027-Z |
0.203 |
|
| 1991 |
Van Praag HM. Is depression a mood disorder? European Neuropsychopharmacology. 1: 193. DOI: 10.1016/0924-977X(91)90480-I |
0.203 |
|
| 1980 |
van Praag HM. Central monoamine metabolism in depressions. II. Catecholamines and related compounds. Comprehensive Psychiatry. 21: 44-54. PMID 6987035 DOI: 10.1016/0010-440x(80)90063-2 |
0.202 |
|
| 1997 |
Honig A, Lousberg R, Wojciechowski FL, Cheriex EC, Wellens HJ, van Praag HM. [Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. Nederlands Tijdschrift Voor Geneeskunde. 141: 196-9. PMID 9064527 |
0.198 |
|
| 2002 |
Van Praag HM. Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression. Neurotoxicity Research. 4: 531-555. PMID 12754165 DOI: 10.1080/1029842021000022115 |
0.196 |
|
| 2001 |
Strik JJ, Honig A, Lousberg R, van Os J, van den Berg EJ, van Praag HM. Clinical correlates of depression following myocardial infarction. International Journal of Psychiatry in Medicine. 31: 255-64. PMID 11841123 DOI: 10.2190/EJBR-DWLH-EV3P-TWHX |
0.195 |
|
| 1988 |
Asnis GM, Eisenberg J, van Praag HM, Lemus CZ, Harkavy Friedman JM, Miller AH. The neuroendocrine response to fenfluramine in depressives and normal controls Biological Psychiatry. 24: 117-120. PMID 3370273 DOI: 10.1016/0006-3223(88)90133-3 |
0.195 |
|
| 1996 |
Menting JE, Honig A, Verhey FR, Hartmans M, Rozendaal N, de Vet HC, van Praag HM. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. International Clinical Psychopharmacology. 11: 165-75. PMID 8923095 |
0.194 |
|
| 1995 |
Van Praag HM. Selectivity and specificity of pharmacotherapy in depression. The place of mirtazapine: Closing remarks Cns Drugs. 4: 49. |
0.194 |
|
| 1977 |
van den Burg W, van Praag HM, Bos ER, Piers DA, van Zanten AK, Doorenbos H. TRH by slow, continuous infusion: an antidepressant? Psychological Medicine. 6: 393-7. PMID 825895 DOI: 10.1017/S0033291700015828 |
0.194 |
|
| 1982 |
van Praag HM. A transatlantic view of the diagnosis of depressions according to the DSM III: I. Controversies and misunderstandings in depression diagnosis. Comprehensive Psychiatry. 23: 315-29. PMID 7116827 DOI: 10.1016/0010-440x(82)90081-5 |
0.193 |
|
| 1990 |
van Praag HM. The DSM-IV (depression) classification: to be or not to be? The Journal of Nervous and Mental Disease. 178: 147-9. PMID 2307967 |
0.191 |
|
| 1995 |
Klaassen T, Verhey FR, Sneijders GH, Rozendaal N, de Vet HC, van Praag HM. Treatment of depression in Parkinson's disease: a meta-analysis. The Journal of Neuropsychiatry and Clinical Neurosciences. 7: 281-6. PMID 7580184 |
0.191 |
|
| 1991 |
Brown SL, Kotler M, Van Praag HM. OCD: A disorder with anxiety, aggression, impulsivity, and depressed mood (Reply) Psychiatry Research. 36: 239. DOI: 10.1016/0165-1781(91)90136-D |
0.19 |
|
| 1993 |
van Praag HM. Diagnosis, the rate-limiting factor of biological depression research. Neuropsychobiology. 28: 197-206. PMID 8272202 |
0.187 |
|
| 1992 |
Asnis GM, Wetzler S, van Praag HM. The interrelationship of serotonin and norepinephrine in man. Clinical Neuropharmacology. 15: 620A-621A. PMID 1498974 |
0.186 |
|
| 1982 |
van Praag HM. The significance of biological factors in the diagnosis of depressions: I. Biochemical variables. Comprehensive Psychiatry. 23: 124-35. PMID 6121677 DOI: 10.1016/0010-440x(82)90057-8 |
0.186 |
|
| 1992 |
Chen J, Paredes W, van Praag HM, Gardner EL. Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen. Brain Research. 582: 173-9. PMID 1379872 DOI: 10.1016/0006-8993(92)90335-7 |
0.185 |
|
| 1980 |
Mendlewicz J, Linkowski P, Guroff JJ, Van Praag HM. Color blindness linkage to bipolar manic-depressive illness. New evidence. Archives of General Psychiatry. 36: 1442-7. PMID 316316 DOI: 10.1001/ARCHPSYC.1979.01780130060007 |
0.184 |
|
| 1989 |
Asnis GM, Friedman JM, Miller AH, Iqbal N, Lo ES, Cooper TB, Halbreich U, Lemus CZ, van Praag HM, Rubinson E. Plasma dexamethasone and cortisol levels in depressed outpatients. Journal of Affective Disorders. 16: 5-10. PMID 2521652 DOI: 10.1016/0165-0327(89)90048-7 |
0.184 |
|
| 1987 |
Plutchik R, van Praag HM. Interconvertability of five self-report measures of depression. Psychiatry Research. 22: 243-56. PMID 3432452 DOI: 10.1016/0165-1781(87)90039-4 |
0.182 |
|
| 1986 |
Van Praag HM. (Auto)aggression and CSF 5-HIAA in depression and schizophrenia Psychopharmacology Bulletin. 22: 669-673. PMID 2432628 |
0.182 |
|
| 2002 |
van Praag HM. Why has the antidepressant era not shown a significant drop in suicide rates? Crisis. 23: 77-82. PMID 12500893 |
0.18 |
|
| 2003 |
Strik JJ, van Praag HM, Honig A. [Depression after first myocardial infarction. A prospective study on incidence, prognosis, risk factors and treatment]. Tijdschrift Voor Gerontologie En Geriatrie. 34: 104-12. PMID 12866252 |
0.179 |
|
| 2003 |
Van Praag HM. A stubborn behaviour: the failure of antidepressants to reduce suicide rates. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 4: 184-91. PMID 14608590 DOI: 10.1080/15622970310029917 |
0.178 |
|
| 2000 |
Strik JJ, Honig A, Lousberg R, Lousberg AH, Cheriex EC, Tuynman-Qua HG, Kuijpers PM, Wellens HJ, Van Praag HM. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosomatic Medicine. 62: 783-9. PMID 11138997 DOI: 10.1097/00006842-200011000-00007 |
0.178 |
|
| 1986 |
Van Praag HM. Indoleamines in depression and suicide Progress in Brain Research. 65: 59-71. PMID 3538162 |
0.177 |
|
| 1998 |
Klaassen T, Ho Pian KL, Westenberg HG, den Boer JA, van Praag HM. Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine. Psychiatry Research. 79: 207-12. PMID 9704867 DOI: 10.1016/S0165-1781(98)00044-4 |
0.176 |
|
| 1986 |
Lemus CZ, Asnis GM, Eisenberg J, Halbreich U, van Praag HM, Zukin SR. Imipramine binding and cortisol in depression. Biological Psychiatry. 21: 1440-1. PMID 3790630 DOI: 10.1016/0006-3223(86)90339-2 |
0.176 |
|
| 1988 |
van Praag HM, Plutchik R. Increased suicidality in depression: group or subgroup characteristic? Psychiatry Research. 26: 273-8. PMID 3265519 DOI: 10.1016/0165-1781(88)90121-7 |
0.173 |
|
| 1991 |
Chen JP, van Praag HM, Gardner EL. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Research. 543: 354-7. PMID 1711914 DOI: 10.1016/0006-8993(91)90050-6 |
0.173 |
|
| 1982 |
van Praag HM. The significance of biological factors in the diagnosis of depressions: II hormonal variables. Comprehensive Psychiatry. 23: 216-26. PMID 6806009 DOI: 10.1016/0010-440x(82)90069-4 |
0.171 |
|
| 1997 |
van Praag H, Pinder RM. Introduction: Remeron (mirtozapine) the designer's approach to depression Acta Psychiatrica Scandinavica, Supplement. 96: 5. |
0.168 |
|
| 1998 |
Strik JJ, Honig A, Lousberg R, Cheriex EC, Van Praag HM. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients. International Clinical Psychopharmacology. 13: 263-7. PMID 9861576 |
0.163 |
|
| 1976 |
Van den Burg W, Van Praag HM, Bos ER, Piers DA, Van Zanten AK, Doorenbos H. Thyrotropin releasing hormone (TRH) as a possible quick-acting but short-lasting antidepressant. Psychological Medicine. 5: 404-12. PMID 812133 DOI: 10.1017/S0033291700057032 |
0.161 |
|
| 1999 |
Riedel WJ, Klaassen T, Deutz NE, van Someren A, van Praag HM. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology. 141: 362-9. PMID 10090643 DOI: 10.1007/s002130050845 |
0.16 |
|
| 1995 |
Gordon ML, Lipton RB, Brown SL, van Praag HM. The neuroendocrine challenge paradigm in headache research. Cephalalgia : An International Journal of Headache. 15: 292-6. PMID 7585926 DOI: 10.1046/j.1468-2982.1995.1504292.x |
0.157 |
|
| 1976 |
van den Burg W, van Praag HM, Bos ER, van Zanten AK, Piers DA. TRH as a possible quick-acting but short-lasting antidepressant. Progress in Brain Research. 42: 68-9. PMID 812147 DOI: 10.1016/S0079-6123(08)63644-4 |
0.156 |
|
| 1994 |
Sevy S, Brown SL, Wetzler S, Kotler M, Molcho A, Plutchik R, van Praag HM. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine. Psychiatry Research. 53: 219-29. PMID 7870844 DOI: 10.1016/0165-1781(94)90051-5 |
0.153 |
|
| 1999 |
Klaassen T, Riedel WJ, Deutz NE, van Someren A, van Praag HM. Specificity of the tryptophan depletion method. Psychopharmacology. 141: 279-86. PMID 10027509 DOI: 10.1007/s002130050835 |
0.152 |
|
| 1998 |
Klaassen T, Klumperbeek J, Deutz NE, van Praag HM, Griez E. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Research. 77: 167-74. PMID 9707299 DOI: 10.1016/S0165-1781(98)00004-3 |
0.151 |
|
| 1997 |
Vorel-Havelkova E, Brombacher PJ, Van Praag HM. Treatment of therapy resistant primary depression [1] | Behandeling van therapieresistente primaire depressie [1] Nederlands Tijdschrift Voor Geneeskunde. 141: 1707-1708. PMID 9543789 |
0.148 |
|
| 1986 |
Van Praag HM, Lemus C, Kahn R. The pitfalls of serotonin precursors as challengers in hormonal probes of central serotonin activity Psychopharmacology Bulletin. 22: 565-570. PMID 3491999 |
0.148 |
|
| 1987 |
van Praag HM, Lemus C, Kahn R. Hormonal probes of central serotonergic activity: Do they really exist? Biological Psychiatry. 22: 86-98. PMID 3539211 DOI: 10.1016/0006-3223(87)90134-X |
0.145 |
|
| 1994 |
Brown SL, Botsis A, Van Praag HM. Serotonin and aggression Journal of Offender Rehabilitation. 21: 27-40. DOI: 10.1300/J076v21n03_03 |
0.145 |
|
| 2002 |
Dijkstra JB, Strik JJ, Lousberg R, Prickaerts J, Riedel WJ, Jolles J, van Praag HM, Honig A. Atypical cognitive profile in patients with depression after myocardial infarction. Journal of Affective Disorders. 70: 181-90. PMID 12117630 DOI: 10.1016/S0165-0327(01)00348-2 |
0.144 |
|
| 2006 |
Van Praag HM. Reply to Dr. Schmidt's remarks on the paper of H.M. Van Praag, "Can stress cause depression?" Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30: 323. DOI: 10.1016/j.pnpbp.2005.08.004 |
0.143 |
|
| 2005 |
van Praag HM. Reply to Dr. Schmidt's remarks on the paper of H.M. van Praag "Can stress cause depression?". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 995. PMID 15972244 DOI: 10.1016/j.pnpbp.2005.04.001 |
0.143 |
|
| 1988 |
Kahn RS, Van Praag HM. A serotonin hypothesis of panic disorder Human Psychopharmacology. 3: 285-288. |
0.142 |
|
| 1991 |
Wetzler S, Asnis GM, van Praag HM. Comment on 5-HT and mechanisms of defence. Journal of Psychopharmacology (Oxford, England). 5: 332-3. PMID 22282835 DOI: 10.1177/026988119100500420 |
0.14 |
|
| 2004 |
van Praag HM. Stress and suicide are we well-equipped to study this issue? Crisis. 25: 80-5. PMID 15387216 DOI: 10.1027/0227-5910.25.2.80 |
0.14 |
|
| 2004 |
van Praag HM. The debit balance of present day stress research. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 5: 155-60. PMID 15346540 DOI: 10.1080/15622970410029928 |
0.138 |
|
| 1997 |
Korn ML, Plutchik R, Van Praag HM. Panic-associated suicidal and aggressive ideation and behavior. Journal of Psychiatric Research. 31: 481-7. PMID 9352474 DOI: 10.1016/S0022-3956(97)00019-8 |
0.135 |
|
| 2000 |
van Praag HM. Nosologomania: a disorder of psychiatry. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1: 151-8. PMID 12607225 DOI: 10.3109/15622970009150584 |
0.13 |
|
| 1986 |
van Praag HM. Biological suicide research: Outcome and limitations Biological Psychiatry. 21: 1305-1323. PMID 2428412 DOI: 10.1016/0006-3223(86)90314-8 |
0.13 |
|
| 2016 |
Leentjens AF, Verhey FR, Vreeling FW, van Praag HM. The role of serotonin in Parkinsons' Disease: An integrated approach for research of motor, cognitive and affective symptoms with functional intervention studies. Acta Neuropsychiatrica. 10: 84-6. PMID 26971892 DOI: 10.1017/S0924270800036425 |
0.129 |
|
| 1992 |
Chen J, Paredes W, Van Praag HM, Lowinson JH, Gardner EL. Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse (New York, N.Y.). 10: 264-6. PMID 1557698 DOI: 10.1002/Syn.890100308 |
0.129 |
|
| 2003 |
Kuijpers PM, Strik JJ, Lousberg R, van de Veen FH, van Praag HM, Wellens HJ, Honig A. Cardiological risk factors for depressive symptoms after a first myocardial infarction. Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 11: 440-446. PMID 25696157 |
0.128 |
|
| 1995 |
Iqbal N, van Praag HM. The role of serotonin in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 11-23. PMID 8775754 DOI: 10.1016/0924-977X(95)00027-M |
0.127 |
|
| 1999 |
Klaassen T, Riedel WJ, van Someren A, Deutz NE, Honig A, van Praag HM. Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biological Psychiatry. 46: 489-97. PMID 10459398 DOI: 10.1016/S0006-3223(99)00082-7 |
0.126 |
|
| 2002 |
Klaassen T, Riedel WJ, Deutz NE, Van Praag HM. Mood congruent memory bias induced by tryptophan depletion. Psychological Medicine. 32: 167-72. PMID 11885569 DOI: 10.1017/S003329170100438X |
0.124 |
|
| 1979 |
Klaver MM, Flentge F, Nienhuis-Kuiper HE, van Praag HM. The origin of CSF choline and its relation to acetylcholine metabolism in brain. Life Sciences. 24: 231-6. PMID 423701 DOI: 10.1016/0024-3205(79)90224-8 |
0.124 |
|
| 1990 |
Sevy S, Kay SR, Opler LA, van Praag HM. Significance of cocaine history in schizophrenia. The Journal of Nervous and Mental Disease. 178: 642-8. PMID 2230749 |
0.118 |
|
| 1988 |
Eisenberg J, Asnis GM, Van Praag HM, Vela RM. Effect of tyrosine on attention deficit disorder with hyperactivity Journal of Clinical Psychiatry. 49: 193-195. PMID 3284877 |
0.118 |
|
| 1983 |
Broderick PA, Gardner EL, van Praag HM. Similar effects of an enkephalin analog on mesolimbic dopamine release and hyperactivity in rats Life Sciences. 33: 635-638. PMID 6686641 DOI: 10.1016/0024-3205(83)90583-0 |
0.117 |
|
| 1996 |
Tuinier S, Verhoeven WMA, Van Praag HM. Serotonin and disruptive behaviour; a critical evaluation of the clinical data Human Psychopharmacology. 11: 469-482. DOI: 10.1002/(SICI)1099-1077(199611)11:6<469::AID-HUP817>3.0.CO;2-X |
0.116 |
|
| 1985 |
De Cuyper H, van Praag HM, Verstraeten D. The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones. Neuropsychobiology. 12: 211-6. PMID 6398861 DOI: 10.1159/000118141 |
0.115 |
|
| 2016 |
van Praag HM. Biological psychiatry marching towards the future and the perils of progress. Acta Neuropsychiatrica. 3: 36-41. PMID 26956077 DOI: 10.1017/s0924270800034190 |
0.115 |
|
| 1989 |
Plutchik R, van Praag HM, Picard S, Conte HR, Korn M. Is there a relation between the seriousness of suicidal intent and the lethality of the suicide attempt? Psychiatry Research. 27: 71-9. PMID 2922447 DOI: 10.1016/0165-1781(89)90011-5 |
0.113 |
|
| 1988 |
Lindenmayer JP, Gardner E, Goldberg E, Opler LA, Kay SR, van Praag HM, Weiner M, Zukin S. High-dose naloxone in tardive dyskinesia. Psychiatry Research. 26: 19-28. PMID 3070611 DOI: 10.1016/0165-1781(88)90083-2 |
0.113 |
|
| 1991 |
Deakin JFW, Graeff FG, Rodgers RJ, Broekkamp CL, Handley SL, McBlane JW, Everitt B, Robbins T, Shepherd JK, Blanchard DC, De Padua Carobrez A, Blanchard RJ, Wetzler S, Asnis GM, Van Praag HM, et al. Critique: 5-HT and mechanisms of defence Journal of Psychopharmacology. 5: 305-341. |
0.111 |
|
| 2000 |
van Praag HM. Serotonin disturbances and suicide risk: is aggression or anxiety the interjacent link? Crisis. 21: 160-2. PMID 11419526 |
0.11 |
|
| 1990 |
van Praag HM. Two-tier diagnosing in psychiatry. Psychiatry Research. 34: 1-11. PMID 1980016 DOI: 10.1016/0165-1781(90)90053-8 |
0.109 |
|
| 1993 |
Asnis GM, Friedman TA, Sanderson WC, Kaplan ML, van Praag HM, Harkavy-Friedman JM. Suicidal behaviors in adult psychiatric outpatients, I: Description and prevalence. The American Journal of Psychiatry. 150: 108-12. PMID 8417551 DOI: 10.1176/Ajp.150.1.108 |
0.109 |
|
| 1994 |
Möller HJ, van Praag HM, Aufdembrinke B, Bailey P, Barnes TR, Beck J, Bentsen H, Eich FX, Farrow L, Fleischhacker WW. Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia. Psychopharmacology. 115: 221-8. PMID 7862898 DOI: 10.1007/Bf02244775 |
0.107 |
|
| 2004 |
van Praag HM. The cognitive paradox in posttraumatic stress disorder: a hypothesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 923-35. PMID 15380853 DOI: 10.1016/j.pnpbp.2004.05.011 |
0.107 |
|
| 2008 |
van Praag HM. Kraepelin, biological psychiatry, and beyond. European Archives of Psychiatry and Clinical Neuroscience. 258: 29-32. PMID 18516514 DOI: 10.1007/s00406-008-2006-1 |
0.106 |
|
| 1987 |
van Praag HM. 5-HT and the functional approach Biological Psychiatry. 22: 1503. PMID 3676381 DOI: 10.1016/0006-3223(87)90114-4 |
0.106 |
|
| 1975 |
van Praag HM, Dols LC, Schut T. Biochemical versus psychopathological action profile of neuroleptics: a comparative study of chlorpromazine and oxypertine in acute psychotic disorders. Comprehensive Psychiatry. 16: 255-63. PMID 237735 DOI: 10.1016/0010-440X(75)90052-8 |
0.105 |
|
| 1998 |
Leentjens AFG, Verhey FRJ, Vreeling FW, Van Praag HM. The role of serotonin in Parkinsons' Disease: An integrated approach for research of motor, cognitive and affective symptoms with functional intervention studies | De rol van serotonine bij M. Parkinson: Een geintegreerde onderzoeksbenadering van motorische, cognitieve en affectieve symptomen door middel van functionele interventie Acta Neuropsychiatrica. 10: 84-86. |
0.103 |
|
| 1990 |
Merriam AE, Kay SR, Opler LA, Kushner SF, van Praag HM. Neurological signs and the positive-negative dimension in schizophrenia. Biological Psychiatry. 28: 181-92. PMID 2378925 DOI: 10.1016/0006-3223(90)90573-K |
0.103 |
|
| 1985 |
De Cuyper H, van Praag HM, Verstraeten D. The effect of milenperone on the aggressive behavior of oligophrenic patients. A double-blind placebo-controlled study. Neuropsychobiology. 13: 101-5. PMID 3900796 DOI: 10.1159/000118170 |
0.102 |
|
| 1996 |
van Praag HM. Comorbidity (psycho) analysed. The British Journal of Psychiatry. Supplement. 129-34. PMID 8864159 |
0.101 |
|
| 1992 |
Bajwa WK, Asnis GM, Sanderson WC, Irfan A, van Praag HM. High cholesterol levels in patients with panic disorder. The American Journal of Psychiatry. 149: 376-8. PMID 1536278 DOI: 10.1176/Ajp.149.3.376 |
0.1 |
|
| 1986 |
De Cuyper H, Bollen J, Van Praag HM, Verstraeten D. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration British Journal of Psychiatry. 148: 560-566. PMID 2877701 |
0.1 |
|
| 2019 |
van Gijn J, van Praag HM. [Are mental and neurological disorders related?] Nederlands Tijdschrift Voor Geneeskunde. 163. PMID 30730687 |
0.099 |
|
| 1991 |
Iqbal N, Asnis GM, Wetzler S, Kay SR, van Praag HM. The role of serotonin in schizophrenia. New findings. Schizophrenia Research. 5: 181-2. PMID 1931810 DOI: 10.1016/0920-9964(91)90046-T |
0.099 |
|
| 1993 |
Gordon ML, Lipton RB, Brown SL, Nakraseive C, Russell M, Pollack SZ, Korn ML, Merriam A, Solomon S, van Praag HM. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia : An International Journal of Headache. 13: 400-5. PMID 8313453 DOI: 10.1046/j.1468-2982.1993.1306400.x |
0.098 |
|
| 1997 |
van Praag HM. Over the mainstream: diagnostic requirements for biological psychiatric research. Psychiatry Research. 72: 201-12. PMID 9406910 DOI: 10.1016/S0165-1781(97)00103-0 |
0.095 |
|
| 1985 |
De Cuyper H, van Praag HM, Verstraeten D. The effect of milenperone on the aggressive behavior of psychogeriatric patients. A double-blind placebo-controlled study. Neuropsychobiology. 13: 1-6. PMID 2863777 DOI: 10.1159/000118153 |
0.095 |
|
| 1975 |
van Praag HM. Neuroleptics as a guideline to biological research in psychotic disorders. Comprehensive Psychiatry. 16: 7-22. PMID 1089049 DOI: 10.1016/0010-440x(75)90016-4 |
0.093 |
|
| 1993 |
Apter A, Plutchik R, van Praag HM. Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatrica Scandinavica. 87: 1-5. PMID 8424318 DOI: 10.1111/J.1600-0447.1993.Tb03321.X |
0.093 |
|
| 1996 |
Honig A, Van Praag HM, Moleman P. Revision of blood levels of tricyclic antidepressant agents | SERUMSPIEGELS VAN TRICYCLISCHE ANTIDEPRESSIVA REVISITED Tijdschrift Voor Psychiatrie. 38: 340-342. |
0.092 |
|
| 1992 |
van Praag HM. About the centrality of mood lowering in mood disorders. Plenary Lecture ECNP Congress, Monte Carlo, October 1991. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2: 393-404. PMID 1362659 |
0.091 |
|
| 1995 |
Plutchik R, Botsis AJ, Van Praag HM. Psychopathology, self-esteem, sexual and ego functions as correlates of suicide and violence risk Archives of Suicide Research. 1: 27-38. DOI: 10.1080/13811119508258972 |
0.09 |
|
| 2007 |
Loonen AJ, van Praag HM. Measuring movement disorders in antipsychotic drug trials: the need to define a new standard. Journal of Clinical Psychopharmacology. 27: 423-30. PMID 17873670 DOI: 10.1097/jcp.0b013e31814f1105 |
0.084 |
|
| 1989 |
Plutchik R, van Praag HM, Conte HR, Picard S. Correlates of suicide and violence risk 1: the suicide risk measure. Comprehensive Psychiatry. 30: 296-302. PMID 2758804 DOI: 10.1016/0010-440X(89)90053-9 |
0.075 |
|
| 1979 |
van Praag HM. Psychopsychiatry: can psychosocial factors cause psychiatric disorders? Comprehensive Psychiatry. 20: 215-25. PMID 446006 DOI: 10.1016/0010-440x(79)90015-4 |
0.075 |
|
| 1991 |
Van Praag HM. Serotonergic dysfunction and aggression control. Psychological Medicine. 21: 15-9. PMID 2047491 |
0.074 |
|
| 2009 |
Van Praag HM. God's Champions and Adversaries: About the Borders between Normal and Abnormal Religiosity Religion and Psychiatry: Beyond Boundaries. 235-251. DOI: 10.1002/9780470682203.ch13 |
0.074 |
|
| 1995 |
Riedel WJ, van Praag HM. Avoiding and Managing Anticholinergic Effects of Antidepressants Cns Drugs. 3: 245-259. DOI: 10.2165/00023210-199503040-00002 |
0.073 |
|
| 2001 |
Van Praag HM. Combination of antidepressant drugs: The case of inositol Human Psychopharmacology. 16: 37-43. DOI: 10.1002/hup.181 |
0.072 |
|
| 1999 |
Havermans R, Honig A, Vuurman EF, Krabbendam L, Wilmink J, Lamers T, Verheecke CJ, Jolles J, Romme MA, van Praag HM. A controlled study of temporal lobe structure volumes and P300 responses in schizophrenic patients with persistent auditory hallucinations. Schizophrenia Research. 38: 151-8. PMID 10463460 DOI: 10.1016/S0920-9964(99)00006-7 |
0.071 |
|
| 1972 |
van Praag HM, Schut T, Dols L, van Schilfgaarden R. Controlled trial of penfluridol in acute psychosis. British Medical Journal. 4: 710-3. PMID 4943034 DOI: 10.1136/bmj.4.5789.710 |
0.071 |
|
| 1974 |
van Praag HM. New developments in human psychopharmacology. Comprehensive Psychiatry. 15: 389-401. PMID 4414809 DOI: 10.1016/0010-440x(74)90038-8 |
0.071 |
|
| 1992 |
Korn ML, Kotler M, Molcho A, Botsis AJ, Grosz D, Chen C, Plutchik R, Brown SL, van Praag HM. Suicide and violence associated with panic attacks. Biological Psychiatry. 31: 607-12. PMID 1581440 DOI: 10.1016/0006-3223(92)90247-W |
0.069 |
|
| 2002 |
Van Praag HM. Disappointments. Why did antidepressants have so little influence on suicide frequency? | Teleurstellingen. Waarom hebben antidepressiva weinig invloed gehad op de siïcidefrequentie? Tijdschrift Voor Psychiatrie. 44: 693-702. |
0.068 |
|
| 1992 |
Korn ML, Botsis AJ, Kotler M, Plutchik R, Conte HR, Finkelstein G, Grosz D, Kay S, Brown SL, van Praag HM. The Suicide and Aggression Survey: a semistructured instrument for the measurement of suicidality and aggression. Comprehensive Psychiatry. 33: 359-65. PMID 1451447 DOI: 10.1016/0010-440X(92)90056-V |
0.068 |
|
| 1994 |
Asnis GM, Kaplan ML, van Praag HM, Sanderson WC. Homicidal behaviors among psychiatric outpatients. Hospital & Community Psychiatry. 45: 127-32. PMID 8168790 DOI: 10.1176/Ps.45.2.127 |
0.068 |
|
| 1989 |
Bleich A, Brown SL, van Praag HM. [The serotonergic hypothesis in schizophrenia]. Harefuah. 116: 204-8. PMID 2659445 |
0.068 |
|
| 1991 |
Apter A, Kotler M, Sevy S, Plutchik R, Brown SL, Foster H, Hillbrand M, Korn ML, van Praag HM. Correlates of risk of suicide in violent and nonviolent psychiatric patients. The American Journal of Psychiatry. 148: 883-7. PMID 2053628 |
0.068 |
|
| 1990 |
Kahn RS, Van Praag HM. Panic disorder: A compendious review | PANIEKSTOORNIS: EEN BEKNOPT OVERZICHT Tijdschrift Voor Psychiatrie. 32: 390-405. |
0.068 |
|
| 1997 |
Gothelf D, Apter A, van Praag HM. Measurement of aggression in psychiatric patients. Psychiatry Research. 71: 83-95. PMID 9255853 DOI: 10.1016/S0165-1781(97)00047-4 |
0.067 |
|
| 1997 |
Van Praag HM. The future of biological psychiatry Cns Spectrums. 2: 18-25. |
0.067 |
|
| 1971 |
van Praag HM. The position of biological psychiatry among the psychiatric disciplines. Comprehensive Psychiatry. 12: 1-7. PMID 5540720 DOI: 10.1016/0010-440x(71)90050-2 |
0.065 |
|
| 1991 |
Van Praag HM. The present and the future of serotonergic drugs Human Psychopharmacology. 6: S13-S19. |
0.065 |
|
| 2008 |
van Praag HM. [Towards deepened psychiatric diagnostics]. Tijdschrift Voor Psychiatrie. 50: 171-2. PMID 18324603 |
0.064 |
|
| 1996 |
van Praag H. Biologering door biologisering van de psychiatrie Dth. 16: 149-152. DOI: 10.1007/BF03060151 |
0.063 |
|
| 1988 |
Van Praag HM. Editorial biological psychiatry audited Journal of Nervous and Mental Disease. 176: 195-199. PMID 3351497 |
0.063 |
|
| 1984 |
Van Praag HM. Socio-biological psychiatry. Comprehensive Psychiatry. 22: 441-50. PMID 6141892 DOI: 10.1016/0010-440x(81)90032-8 |
0.062 |
|
| 1994 |
Honig A, van Praag HM. [Mania: clinical aspects, cause and treatment]. Nederlands Tijdschrift Voor Geneeskunde. 138: 894-8. PMID 7910954 |
0.062 |
|
| 1994 |
Honig A, Van Praag HM. Mania: Clinical aspects, cause and treatment [2] | MANIE: KLINIEK, OORZAAK EN BEHANDELING [2] Nederlands Tijdschrift Voor Geneeskunde. 138: 1383. PMID 8035899 |
0.061 |
|
| 1989 |
Plutchik R, van Praag HM, Conte HR. Correlates of suicide and violence risk: III. A two-stage model of countervailing forces. Psychiatry Research. 28: 215-25. PMID 2748772 DOI: 10.1016/0165-1781(89)90048-6 |
0.061 |
|
| 1989 |
Van Praag HM. Serotonergic mechanisms in the pathogenesis of schizophrenia | SEROTENERGE MECHANISMEN IN DE PATHOGENESE VAN SCHIZOFRENE PSYCHOSEN Acta Neuropsychiatrica. 1: 28-33. |
0.06 |
|
| 2009 |
Van Praag HM. Seat of the Divine: A Biological 'Proof of God's Existence'? Religion and Psychiatry: Beyond Boundaries. 523-539. DOI: 10.1002/9780470682203.ch29 |
0.059 |
|
| 1991 |
Van Praag HM. Biological psychiatry marching towards the future and the perils of progress | DE BIOLOGISCHE PSYCHIATRIE OP WEG NAAR DE TOEKOMST EN DE GEVAREN VAN VOORUITGANG Acta Neuropsychiatrica. 3: 36-41. |
0.059 |
|
| 2011 |
Blom JD, van Praag HM. Schizophrenia: it's broken and it can't be fixed. A conceptual analysis at the centenary of Bleuler's Dementia praecox oder Gruppe der Schizophrenien. The Israel Journal of Psychiatry and Related Sciences. 48: 240-8. PMID 22572087 |
0.059 |
|
| 1992 |
Brown SL, Botsis AJ, Van Praag HM. Suicide: CSF and neuroendocrine challenge studies International Review of Psychiatry. 4: 141-148. DOI: 10.3109/09540269209066311 |
0.059 |
|
| 2010 |
van Praag HM. [Loss of sense and meaning, a neglected topic in psychiatry]. Tijdschrift Voor Psychiatrie. 52: 705-14. PMID 20931484 |
0.058 |
|
| 2002 |
Van der Heijden FMMA, Tuinier S, Pepplinkhuizen L, Van Praag HM, Verhoeven WMA. Beyond the mainstream: The heuristic value of the cycloid psychosis European Journal of Psychiatry. 16: 15-26. |
0.056 |
|
| 1988 |
Van Praag HM. Serotonergic mechanisms and suicidal behavior Psychiatrie Et Psychobiologie. 3: 335-346. |
0.056 |
|
| 1986 |
van Praag HM. Psychiatrists, beware of dichotomies! Biological Psychiatry. 21: 247-248. PMID 3947706 |
0.056 |
|
| 1992 |
van Praag HM. Reconquest of the subjective. Against the waning of psychiatric diagnosing. The British Journal of Psychiatry : the Journal of Mental Science. 160: 266-71. PMID 1489370 |
0.056 |
|
| 1985 |
Ieni JR, Tobach E, Zukin SR, Barr GA, Van Praag HM. Multiple [3H]imipramine binding sites in brains of male and female Fawn-Hooded and Long-Evans rats. European Journal of Pharmacology. 112: 261-4. PMID 2992999 DOI: 10.1016/0014-2999(85)90506-0 |
0.055 |
|
| 1999 |
van Praag HM. The impact of classification on psychopharmacology and biological psychiatry. Dialogues in Clinical Neuroscience. 1: 141-51. PMID 22034250 |
0.054 |
|
| 2010 |
Van Praag HM. Zinverlies; een verwaarloosd onderwerp in de psychiatrie (Tijdschrift voor Psychiatrie (2010) 10, (705-714)) Tijdschrift Voor Psychiatrie. 52: 805. |
0.054 |
|
| 1990 |
Plutchik R, van Praag HM. A self-report measure of violence risk, II. Comprehensive Psychiatry. 31: 450-6. PMID 2225805 DOI: 10.1016/0010-440X(90)90031-M |
0.054 |
|
| 1984 |
Ieni JR, Zukin SR, Van Praag HM. Human platelets possess multiple [3H]imipramine binding sites. European Journal of Pharmacology. 106: 669-72. PMID 6097465 DOI: 10.1016/0014-2999(84)90078-5 |
0.053 |
|
| 1973 |
van Praag HM, Dols LC. Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. The American Journal of Psychiatry. 130: 801-4. PMID 4576449 DOI: 10.1176/AJP.130.7.801 |
0.051 |
|
| 2005 |
De Kroon JAM, Van Praag HM. Response to "Why retain a diagnosis of schizophrenia?" and "Why no diagnosis of schizophrenia?" (multiple letters) | Reactie op 'Waarom een diagnose schizojrenie?' en 'Waarom seen diagnose schizofrenie' Tijdschrift Voor Psychiatrie. 47: 397-398. |
0.051 |
|
| 1989 |
Apter A, Plutchik R, Sevy S, Korn M, Brown S, van Praag H. Defense mechanisms in risk of suicide and risk of violence. The American Journal of Psychiatry. 146: 1027-31. PMID 2750974 |
0.051 |
|
| 1997 |
Griez EJL, Van Praag HM. Psychopharmacological agents in prospect | Psychofarmaca in perspectief beschouwd Pharmaceutisch Weekblad. 132: 560-563. |
0.05 |
|
| 2009 |
van Praag HM. The Need to Functionalise Psychiatric Diagnosis Depressive Disorders, Third Edition. 44-46. DOI: 10.1002/9780470745892.ch1f |
0.049 |
|
| 1995 |
van Praag HM. Zijn de nadagen van de psychotherapie in zicht? Tijdschrift Voor Psychotherapie. 21: 304-306. DOI: 10.1007/BF03079266 |
0.049 |
|
| 2005 |
De Kroon JAM, Harms HH, Havenaar JM, Van Praag HM. Why retain a diagnosis of schizophrenia? [1] (multiple letters) | Reactie op 'waarom een diagnose schizofrenie?' En 'waarom geen diagnose schizofrenie' (1) Tijdschrift Voor Psychiatrie. 47: 331-334. |
0.049 |
|
| 1995 |
Reidel W, Hogervorst E, Leboux R, Verhey F, van Praag H, Jolles J. Caffeine attenuates scopolamine-induced memory impairment in humans Psychopharmacology. 122: 158-168. PMID 8848531 DOI: 10.1007/Bf02246090 |
0.048 |
|
| 1995 |
Botsis AJ, Plutchik R, Kotler M, van Praag HM. Parental loss and family violence as correlates of suicide and violence risk. Suicide & Life-Threatening Behavior. 25: 253-60. PMID 7570786 DOI: 10.1111/J.1943-278X.1995.Tb00924.X |
0.047 |
|
| 1984 |
van Praag HM, Nijo L. About the course of schizoaffective psychoses. Comprehensive Psychiatry. 25: 9-22. PMID 6199158 DOI: 10.1016/0010-440X(84)90017-8 |
0.046 |
|
| 2005 |
Van Praag HM. Why no diagnosis of Schizophrenia? Commentary to the article by J.M. Havenaar | Waarom geen diagnose schizofrenie (sec): Commentaar op Havenaar Tijdschrift Voor Psychiatrie. 47: 157-159. |
0.043 |
|
| 2001 |
Van Praag HM. Past expectations, present disappointments, future hopes or psychopathology as the rate-limiting step of progress in psychopharmacology. Human Psychopharmacology. 16: 3-7. PMID 12404592 DOI: 10.1002/hup.177 |
0.042 |
|
| 2010 |
VAN Praag HM. Biological psychiatry: still marching forward in a dead end. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 9: 164-5. PMID 20975860 |
0.041 |
|
| 1990 |
Kahn RS, Van Praag HM. Response to the commentary by Dr. Van Der Molen Tijdschrift Voor Psychiatrie. 32: 712-714. |
0.041 |
|
| 1976 |
van Praag HM. About the impossible concept of schizophrenia. Comprehensive Psychiatry. 17: 481-97. PMID 963992 DOI: 10.1016/0010-440x(76)90031-6 |
0.04 |
|
| 1993 |
Kotler M, Finkelstein G, Molcho A, Botsis AJ, Plutchik R, Brown SL, van Praag HM. Correlates of suicide and violence risk in an inpatient population: coping styles and social support. Psychiatry Research. 47: 281-90. PMID 8372164 DOI: 10.1016/0165-1781(93)90085-U |
0.039 |
|
| 2011 |
Blom JD, van Praag HM. Functionalization revisited. A Reply to Jablensky's "Schizophrenia: Cracked but on the way to repair" Israel Journal of Psychiatry and Related Sciences. 48: 250-251. |
0.038 |
|
| 1993 |
van Praag HM. [What is self-evident but does not occur as a matter-of-course; observations on the report about biological psychiatry]. Nederlands Tijdschrift Voor Geneeskunde. 137: 366-8. PMID 8437636 |
0.038 |
|
| 1990 |
Asnis GM, Harkavy Friedman JM, Iqbal N, Bajwa WK, Kalus O, Rubinson E, Grosz D, van Praag HM, Cooper TB. The drug-free period: a methodological issue. Biological Psychiatry. 27: 657-60. PMID 2182134 DOI: 10.1016/0006-3223(90)90534-9 |
0.037 |
|
| 2012 |
Loonen AJ, Leonard BE, van Praag HM. Little hope for further innovations in psychopharmacology? Human Psychopharmacology. 27: 437-9. PMID 22996615 DOI: 10.1002/hup.2252 |
0.037 |
|
| 2004 |
van Praag HM. Functionalizing diagnostics. The American Journal of Psychiatry. 161: 2138. PMID 15514432 DOI: 10.1176/appi.ajp.161.11.2138 |
0.035 |
|
| 2011 |
Van Praag HM. Re: Disease versus dimension in diagnosis Canadian Journal of Psychiatry. 56: 128. |
0.035 |
|
| 2010 |
Shorter E, van Praag HM. Disease versus dimension in diagnosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 59-64. PMID 20181300 |
0.035 |
|
| 2010 |
Van Praag HM. Disease versus dimension in diagnosis [2] Canadian Journal of Psychiatry. 55: 687-688. |
0.035 |
|
| 1992 |
van Praag HM. Concluding Remarks Drugs. 43: 55-57. DOI: 10.2165/00003495-199200432-00009 |
0.034 |
|
| 1980 |
van Praag HM. Tablets and talking--a spurious contrast in psychiatry. Comprehensive Psychiatry. 20: 502-10. PMID 509922 DOI: 10.1016/s0010-440x(79)80002-4 |
0.034 |
|
| 2011 |
Van Praag HM. Biological psychiatry: Still marching forward in a dead end | Psychiatria biologiczna: Cia̧gle maszeruje naprzód w ślepym zaułku Postepy Psychiatrii I Neurologii. 20: 16-18. |
0.031 |
|
| 2003 |
van Praag HM. Itinerary: Concerning the professional and spiritual objectives of my life. Medical Humanities. 29: 89-96. PMID 23671218 DOI: 10.1136/mh.29.2.89 |
0.031 |
|
| 2003 |
Van Praag HM. The debit balance of current stress research | De debetzijde van het hedendaagse stressonderzoek in de psychiatrie Tijdschrift Voor Psychiatrie. 45: 141-148. |
0.03 |
|
| 1992 |
Spitzer M, Schwartz JA, Van Praag HM. Reconquest of the subjective [3] British Journal of Psychiatry. 161: 420-421. PMID 1393321 DOI: 10.1192/bjp.161.3.420b |
0.028 |
|
| 2005 |
Van Praag HM. Introduction Mood Disorders: Clinical Management and Research Issues. xiii-xv. DOI: 10.1002/0470094281.ch |
0.025 |
|
| 2010 |
Van Praag HM. No functional psychopharmacology without functional psychopathology. Acta Psychiatrica Scandinavica. 122: 438-9. PMID 20958273 DOI: 10.1111/j.1600-0447.2010.01629.x |
0.025 |
|
| 1997 |
Van Praag HM. Anchorpoints: An introspective Acta Neuropsychiatrica. 9: 38-46. |
0.025 |
|
| 1995 |
van Praag HM. Closing Remarks Cns Drugs. 4: 49-49. DOI: 10.2165/00023210-199500041-00008 |
0.023 |
|
| 1988 |
van Praag HM. The teaching of psychiatry: A statue without a socle Biological Psychiatry. 24: 863-864. PMID 3233230 |
0.023 |
|
| 2013 |
van Praag HM. Religiosity, a personality trait to be reckoned within psychiatry. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 12: 33-4. PMID 23471792 DOI: 10.1002/wps.20006 |
0.021 |
|
| 1986 |
Van Praag HM. On teaching learning theory and behavior therapy to psychiatrists The American Journal of Psychiatry. 143: 804. PMID 3717410 |
0.02 |
|
| 1977 |
van Praag HM. Psychotropic drugs in the aged. Comprehensive Psychiatry. 18: 429-42. PMID 891164 DOI: 10.1016/0010-440x(77)90041-4 |
0.02 |
|
| 2004 |
Van Praag HM. Let the facts prevail. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 5: 116. PMID 15179672 DOI: 10.1080/15622970410029921 |
0.02 |
|
| 1989 |
van Praag HM. Rehabilitative psychiatry. Biological Psychiatry. 26: 437. PMID 2790091 |
0.016 |
|
| 1998 |
Hutto B, Hill C, Van Praag HM. Letter to the editor (multiple letters) Cns Spectrums. 3: 58. |
0.015 |
|
| 2009 |
Verhagen PJ, van Praag HM, López-Ibor JJ, Cox JL, Moussaoui D. Religion and psychiatry: Beyond boundaries Religion and Psychiatry: Beyond Boundaries. 1-667. DOI: 10.1002/9780470682203 |
0.01 |
|
| 2008 |
Van Praag HM. Reply to Goekoop | Antwoord aan Goekoop Tijdschrift Voor Psychiatrie. 50: 395. |
0.01 |
|
| 2003 |
Van Praag HM. On holy cows and golden calves Acta Neuropsychiatrica. 15: 22-25. DOI: 10.1034/j.1601-5215.2003.00005.x |
0.01 |
|
| 1994 |
Plutchik R, Van Praag HM. Sucide risk Journal of Offender Rehabilitation. 21: 173-186. DOI: 10.1300/J076V21N03_11 |
0.01 |
|
| 1991 |
Brown SL, Kotler M, van Praag HM. In reply Psychiatry Research. 36: 239. |
0.01 |
|
| 1990 |
Van Praag HM. (Re-)minding our business Human Psychopharmacology. 5: 1-2. |
0.01 |
|
| 1987 |
Van Praag H. Psychiatrist: Endangered species Human Psychopharmacology: Clinical and Experimental. 2: 59-60. DOI: 10.1002/hup.470020202 |
0.01 |
|
| 1981 |
van Praag HM. Growth and inflation in psychiatry. Comprehensive Psychiatry. 22: 114-23. PMID 7460560 DOI: 10.1016/0010-440x(81)90058-4 |
0.01 |
|
| Hide low-probability matches. |
